A detailed history of Ballast Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ballast Advisors LLC holds 2,537 shares of ABBV stock, worth $516,406. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,537
Previous 2,721 6.76%
Holding current value
$516,406
Previous $466,000 7.51%
% of portfolio
0.16%
Previous 0.15%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$163.84 - $199.33 $30,146 - $36,676
-184 Reduced 6.76%
2,537 $501,000
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $26,469 - $30,909
171 Added 6.71%
2,721 $466,000
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $27,009 - $30,774
-169 Reduced 6.22%
2,550 $464,000
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $275 - $309
2 Added 0.07%
2,719 $421,000
Q3 2023

Oct 19, 2023

SELL
$133.59 - $154.65 $11,087 - $12,835
-83 Reduced 2.96%
2,717 $404,000
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $9,540 - $11,872
-72 Reduced 2.51%
2,800 $377,000
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $10,701 - $12,323
74 Added 2.64%
2,872 $457,000
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $5,947 - $7,132
-43 Reduced 1.51%
2,798 $0
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $3,086 - $3,540
-23 Reduced 0.8%
2,841 $381,000
Q2 2022

Jul 20, 2022

BUY
$137.62 - $174.96 $3,440 - $4,374
25 Added 0.88%
2,864 $439,000
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $131 - $163
1 Added 0.04%
2,839 $460,000
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $107 - $135
1 Added 0.04%
2,838 $384,000
Q3 2021

Nov 01, 2021

BUY
$106.4 - $120.78 $212 - $241
2 Added 0.07%
2,837 $306,000
Q2 2021

Jul 20, 2021

SELL
$105.21 - $117.21 $29,879 - $33,287
-284 Reduced 9.11%
2,835 $319,000
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $19,539 - $21,510
191 Added 6.52%
3,119 $338,000
Q4 2020

Feb 05, 2021

BUY
$80.49 - $108.67 $160 - $217
2 Added 0.07%
2,928 $314,000
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $85 - $100
1 Added 0.03%
2,926 $256,000
Q2 2020

Jul 29, 2020

BUY
$73.37 - $98.18 $35,437 - $47,420
483 Added 19.78%
2,925 $287,000
Q1 2020

Apr 16, 2020

SELL
$64.5 - $97.79 $11,223 - $17,015
-174 Reduced 6.65%
2,442 $186,000
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $188,692 - $236,094
2,616 New
2,616 $232,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ballast Advisors LLC Portfolio

Follow Ballast Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballast Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballast Advisors LLC with notifications on news.